Because angiogenesis is an important phenomenon for tumor growth, it is considered a suitable target in anti-tumor drug development strategies; we hypothesized that MSSV also demonstrates anti-angiogenic effects via suppression of VEGF-induced angiogenic responses. Here, VEGFA is linked to neoplasm.